Global Nasal Cannula Market Size To Exceed USD 14.82 Billion By 2033 | CAGR OF 6.43%
Category: HealthcareGlobal Nasal Cannula Market Size To Exceed USD 14.82 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Nasal Cannula Market Size to Grow from USD 7.95 Billion in 2023 to USD 14.82 Billion by 2033, at a CAGR of 6.43% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 200 pages with 110 Market data tables and figures & charts from the report on the "Global Nasal Cannula Market Size, Share, and COVID-19 Impact Analysis, By Type (Low Flow and High Flow), By Material (Silicon and Plastic), By End-User (Hospital, Specialty Clinic, Long Term Care Center, ASC and Homecare), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033."Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/nasal-cannula-market
A nasal cannula is a medical device that uses the nose to deliver additional oxygen to patients, frequently referred to as oxygen treatment or supplementary oxygen. A tiny, flexible tube called a nasal cannula is inserted into the nose and wrapped around the head. Two spikes are used to provide oxygen within the nostrils. The oxygen cylinder is fixed to the tube. Nasal cannulas are classified into two categories: high-flow and low-flow. A nasal cannula can help those who are unable to breathe or who do not get enough oxygen into their system. Numerous medical disorders, such as asthma, heart failure, pneumonia, COVID-19, pulmonary fibrosis, and chronic obstructive pulmonary disease, can be managed with nasal cannulas. The increasing number of geriatric populations can increase the chances of asthma and COPD. Additionally, patients with respiratory diseases frequently need high-flow oxygen therapy through the nasal cannula. Thus, the rising demand for nasal cannula is boosting the growth of the nasal cannula market during the predicted time period. However, the increasing use of nasal cannulas can cause several bacterial infections that bacteria or viruses transmit through the cannula. Furthermore, using long-term oxygen therapy can cause severe side effects, such as lung damage, eye damage, and airway damage (pulmonary oxygen toxicity can restrain the growth of the nasal cannula market over the predicted timeframe).
The low flow segment dominates the market with the largest revenue share through the forecast period.
Based on the type, the global nasal cannula market is segmented into low flow and high flow. Among these, the low-flow segment dominates the market with the largest revenue share through the forecast period. Low-flow nasal cannulas usually serve to provide patients with respiratory disorders with carefully and accurately controlled amounts of oxygen. Those with limited budgets may acquire nasal cannulas, and they are an excellent choice for those who frequently need oxygen supplements.
The plastic segment dominated the global nasal cannula market in 2023.
Based on the material, the global nasal cannula market is segmented into silicon and plastic. Among these, the plastic segment dominated the global nasal cannula market in 2023. Plastic nasal cannulas are widely available and less expensive for manufacturers to manufacture than silicon ones. Because of their affordability, which is particularly important in countries with forecast limitations, they are typically utilized in a variety of healthcare sectors. Patients who have been using plastic nasal cannulas for numerous years’ experience improved comfort and flexibility.
The hospital segment accounted for the largest market share in 2023.
Based on the end-user, the global nasal cannula market is segmented into hospital, specialty clinics, long-term care center, ACS, and homecare. Among these, the hospital segment accounted for the largest market share in 2023. A larger market share is indicated by the increasing use of high-flow nasal cannulas for severe respiratory illnesses, which require high flow. It is anticipated that patients with chronic respiratory conditions and elderly people will fuel market expansion. The positive effects of early detection and treatment of respiratory issues are becoming more widely known to patients and healthcare professionals, which may support market growth.
North America dominates the market with the largest market share over the forecast period.
Get more details on this report -
North America dominates the market with the largest share over the forecast period. The region's market is growing due to the high incidence of respiratory illnesses, well-developed healthcare facilities, and attractive compensation regulations. This region's dominance in the nasal cannula market is caused by the presence of major companies in the industry, cutting-edge technology, and a strong emphasis on enhancing respiratory care. These factors are propelling the growth of the nasal cannula market over the forecast period.
The Asia-Pacific region is expected to grow at the fastest rate during the predicted timeframe. Growing healthcare expenditures and increasing local manufacturing companies are driving the growth of the market. Furthermore, throughout the forecast period, the Asia-Pacific nasal cannula market is expected to develop due to better healthcare facilities, a growing approach to healthcare services, and rising demand for home healthcare solutions.
Major vendors in the global nasal cannula market are ResMed Inc., Teleflex Incorporated, Fisher & Paykel Healthcare Limited, Allied Healthcare Products Inc., Vygon, Salter Labs, Besmed Health Business Corp., Great Group Medical Co. Ltd., Drive DeVilbiss Healthcare, Progetti S.r.l., Flexicare Medical, MAQUET Holding B.V. & Co. KG, GALEMed Corporation, Fairmont Medical, Vapotherm Inc., Smiths Medical and Other Key Players.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In August 2021, ResMed, a top medical device company, launched AirSense 11 in the United States. This device represents the latest generation positive airway pressure (PAP) device of the company, specially developed circulate advance therapy for the management of sleep apnea and treatment.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Nasal Cannula Market based on the below-mentioned segments:
Global Nasal Cannula Market, By Type
- Low Flow
- High Flow
Global Nasal Cannula Market, By Material
- Silicon
- Plastic
Global Nasal Cannula Market, By End-User
- Hospital
- Specialty Clinic
- Long Term Care Center
- ASC
- Homecare
Global Nasal Cannula Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?